Daily Activities

UPSC Prelims Current Affairs

UPSC Mains Current Affairs

Current Affairs

DCGI

The DCGI, or Drug Controller General of India, oversees drug regulation in India. It ensures the safety, efficacy, and quality of pharmaceuticals. The DCGI plays a crucial role in approving new drugs and clinical trials. It also monitors adverse drug reactions. This body is essential for public health and safety in the Indian healthcare system. Its decisions impact millions of lives.

Truenat Test to Detect Nipah Virus

Kerala has received approval from the Indian Council for Medical Research (ICMR) to employ the Truenat test for diagnosing Nipah virus infections. The Truenat test employs a portable,...

 September 22, 2023

GEMCOVAC-OM omicron specific Vaccine

The Omicron variant of COVID-19 has presented new challenges in the fight against the pandemic, emphasizing the need for variant-specific vaccines. In a significant development, the Omicron-specific mRNA-based...

 June 23, 2023

Duchenne Muscular Dystrophy

Researchers in India are working on developing an affordable treatment for a rare and incurable genetic disorder called Duchenne Muscular Dystrophy (DMD) which affects over 5 lakh people...

 January 11, 2023

Nirmatrelvir

Pharmaceutical company Hetero announced on December 26th that it has received World Health Organization Prequalification of Medicines Programme (WHO PQ) approval for its generic version of Covid-19 oral...

 December 29, 2022

Countrywide COVID-19 vaccine Dry Run

Union Ministry of Health and Family Welfare has notified that a country-wide COVID-19 vaccination exercise will be conducted in all States and Union Territories on January 8. This...

 January 7, 2021

Health Ministry’s Warning on Fake CoWIN Apps

The Ministry of Health and Family Welfare has issued a warning for people related to the fake CoWIN (COVID Intelligence Network) app on Play stores. As per the...

 January 7, 2021

SII’s Covishield Gets Emergency-Use Nod from DGCI

The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has given emergency-use approval to the Serum Institute of India's vaccine candidate-Covishield. The approval was...

 January 2, 2021

Bharat Biotech applied for ‘Emergency Use Authorisation’

The developer of indigenous COVID-19 vaccine, Bharat Biotech, has applied to the central drug regulator (DCGI) and asked for the permission of emergency use authorisation for its vaccine...

 December 8, 2020

Emergency Use Authorisation

In normal times, drugs and vaccines required to be tested and approved by regulatory authorities of a country before they can be commercially used. But Emergency Use Authorisation...

 December 7, 2020

DCGI Directs States to Prohibit Online Medicine Sales

In the latest developments, the Drugs Controller General of India (DCGI) has issued a directive to all states and Union territories. This directive prohibits the sale of medicines...

 December 5, 2019

Archives